TIBBİ PAZARLAMANIN REÇETELENDİRME KARAR SÜRECİNE ETKİLERİ ÜZERİNE SİSTEMATİK BİR YAZIN TARAMASI

Dünya’da gelişmiş ve gelişmekte olan pazar ülkelerde yasal değişiklikler, ticaret savaşları ve muadil ile orijinal ilaçlar arasında rekabet artışı nedeniyle ilaç endüstrisindeki dinamikler değişmektedir. Tıbbi ilaç alanında alternatiflerin yükselmesi nedeniyle artan rekabet, hekimlerin reçetelendirme kararlarına etki eden faktörler, faaliyet gösteren tıbbi firmaların pazarlama faaliyetlerini dikkate almasını kaçınılmaz hale getirmektedir. Tıbbi ilaç reçete yazmada, hekimlerin davranışları veya alışkanlıkları ilaç endüstrisinin tanıtım faaliyetlerine göre şekillenmektedir. İlaç sektöründe pazarlama faaliyetleri reçete yazma aşamasında ön plana çıktığından, hekimlerin davranışsal etkisini inceleyen araştırmalar bu çalışmanın temelini oluşturmaktadır.

A SYSTEMATIC REVIEW OF THE EFFECTS OF MEDICINE MARKETING ON PRESCRIBING DECISION PROCESS

The dynamics in the pharmaceutical industry have been changed due to legal amendments in the developed and developing market countries around the world, trade wars, and increased competition between equivalent and original drugs. Increased competition due to the rise of alternatives in the field of medical drugs, factors affecting physicians' prescribing decisions, make it inevitable for the medical companies operating to take into account their marketing activities. In medical drug prescribing, physicians' behaviors or habits are shaped according to the promotion activities of the pharmaceutical industry. Since the marketing activities in the pharmaceutical sector have come to the forefront during the prescribing phase, the researches that examine the behavioral effects of physicians constitute the basis of this study.

___

  • Abacıoğlu, N. (2010) “Türkiye’de İlaç Sanayi” İTO Yayınları, İstanbul.AİFD (Araştırmacı İlaç Firmaları Derneği), (2008) “Sağlık Mesleği Mensuplarıyla İlişkiler Ve Beşeri Tıbbi Ürünlerin Sağlık Mesleği Mensuplarına Tanıtım İlkeleri” Alowi, M., Kani, Y. (2018) “Impact of Pharmaceutical Companies’ Promotional Tools on Physicians’ Prescription Patterns: A Systematic Review” Journal Of Applied Pharmacy, Vol. 10, No. 3, pp.1-10.Amanda, L. G., Hogerzeil, H. V., Ruskamp, F. M. H. (1999) “Intervention Research in Rational Use Of Drugs: A Review” Health Policy And Planning, Vol. 14, No. 2, pp. 89-102.Baykal, Y. M. (2017) “Tıbbi Cihaz Sektöründe Bütünleşik Pazarlama İletişimi Çabaları: Medtronic Medikal Firması Örneği” Yüksek Lisans Tezi, Aydın.Bülbüloğlu, S. (2014) “The Influencers of Prescription Decision And The Relationship Between Doctors Ethnocentric Tendencies And Prescription Decision” Yeditepe University Gradute Institute Of Social Science, Yüksek Lisans Tezi, İstanbul.Demirkıran, M., Şahin, B. (2010) “Pratisyen Hekimlerin İlaç Seçimlerini Etkileyen Faktörlere İlişkin Değerlendirmeleri” Hacettepe Sağlık İdaresi Dergisi, Cilt: 13, Sayı: 1.Düzcü, T., Akyol, M., Sancar, O. (2017) “Ürün Tanıtım Temsilcilerinin Yeterlilik Eğitimindeki Başarı Düzeylerinin Demografik Özellikleriyle Karşılaştırılması” Hacettepe Sağlık İdaresi Dergisi, Vol. 20, No. 2, s. 203-218.Epstein, A. J., Ketcham, J. D. (2010) “Influencing Physicians’ Prescribing Decision Through Detailing, Samples, Prior Authorizations And Patient Copays” W.P. Carey School Of Business, Arizona State University. Grand, A. L., Hogerzeil, H. V., Ruskamp, M. H. (1999) “Intervention Research in Rational Use Of Drugs: A Review” Health Policy And Planning, Vol. 14, No.2, pp. 89-102.Greenway, T., Ross, J. R. (2017) “Us Drug Marketing: How Does Promotion Correspond With Health Value?” The Bmj.Jamshed, S. Q., Ibrahim, M. I. M., Hassali, M. A. A., Masood, I., Low, B. Y., Shafıe, A. A., Babar, Z. D. (2012) “Perception And Attitude Of General Practitioners Regarding Generic Medicines in Karachi, Pakistan: A Questionnaire Based Study” South Med. Review, Vol. 5, No. 1, pp. 22-30.Johnson, E. M. (2002) “Fundamentals of Marketing” American Management Associaton, 4. Baskı.Kayaalp, S. O. (2018) “Akılcıl Tedavi Yönünden Tıbbi Farmakoloji” Pelikan Kitabevi, 13. Baskı.Kotler, P., Amrstrong G. (2014) “Principles of Marketing” Pearson Education Limited, Global Edition, UK.Lieb, K., Scheurich, A. (2014) “Contact Between Doctors And The Pharmaceutical Industry, Their Perceptions, And The Effects on Prescribing Habits” Plos One, Vol. 9, No. 10, pp. 1-8.Lidstone, J., Maclennan, J. (1999) “Marketing Planning For The Pharmaceutical Industry” Routledge, London.Murshid, M. A., Mohaidin, Z., Nee, G. Y. (2016) “Moderating Effects of Contextual Factors on Relationship Between Pharmaceutical Marketing Strategies And Physician Prescription Decision: A Review” Tropical Journal Of Pharmaceutical Research, Vol.15, No. 7, pp. 1559-1568.Murshid, M. A., Mohaidin, Z. (2017) “Models And Theories of Prescribing Decisions: A Review And Suggested A New Model” Pharmacy Practice, Vol.15, No. 2, pp. 1-12.Murshid, M. A., Mohaidin, Z. (2018) “Physicians’ Perceptions Towards Brand Medicine And Its Effect On Prescribing: A Narrative Review” Journal Of Generic Medicines, Vol.13, No. 4, pp. 157-183.Murshid, M. A., Mohaidin, Z. (2018) “The Influence Of Information, Brand, Medical Representatives And Sales Promotion On Physician Presciribing Decision” Journal Of Pharmaceutical Health Services Research, Vol. 9, pp. 259-269.Othman, N., Vıtry, A. I., Roughead, E., Ismail, S. B., Omar, K. (2015) “Doctors’ Views On The Quality Of Claims Provided By Pharmaceutical Representatives: A Comparative Study in Malaysia And Australia” Journal Of Taibah University Medical Sciences, Vol. 10, No. 4, pp. 471-480.Parker, R. S., Pettıjohn, C. E. (2005) “Pharmaceutical Drug Marketing Strategies And Tactics: A Comparative Analysis Of Attitudes Held By Pharmaceutical Representatives And Physicians” Health Marketing Quarterly, Vol. 22, No. 4, pp. 27-43.Pathak, G. P., Bhola, S. S. (2013) “Impact Of Promotional Items On Business Outcomes in Pharmaceutical Industry” Pravara Management Review, Vol 12, No. 2, pp. 38-45.Petra, D. (1994) “Drug Choice In Medical Practice: Rationales, Routines And Remedies” Proefschrift, Groningen. Saito, S., Mukohara, K., Bito, S. (2010) “Japanese Practicing Physicians' Relationships With Pharmaceutical Representatives: A National Survey” Plos One, Vol. 5, pp. 1-7.Salman, A. N., Uydacı, M. (2011) “Butik Hastanelerde Pazarlama Stratejileri” Öneri Dergisi, Vol. 9, No. 35, pp.45-50.Scheffer, M. C. (2014) “Interaction Between Pharmaceutical Companies And Physicians Who Prescribe Antiretroviral Drugs For Treating Aıds” Sao Paulo Med. J. Vol. 132, No. 1, pp. 55-60.Schwartz, L. M., Woloshın, S. (2019) “Medical Marketing in The United States, 1997-2016” Clinical Review And Education, Vol. 321, No. 1, pp. 80-96.Sharifnia, S. H., Mohammadzadeh, M., Arzanı, G., Salamzadeh, J. Abolfazl, A., Zali, A., Khoshdel, A. R. (2018) “Main Factors Affecting Physicians’ Prescribing Decisions: The Iranian Experience” Vol. 17, No. 3, pp. 1105-1115.Sherlekar, S. A., Prasad, K. N., Victor, J. S. (2010) “Principles of Marketing” Himayala Publishing House, Revised Edition, India.Stros, M., Lee, N. (2015) “Marketing Dimensions in The Prescription Pharmaceutical Industry: A Systematic Literature Review” Journal Of Strategic Marketing, Vol. 23, No. 4, pp. 318-336.Tosun, N. Kurtuluş, S. A. (2017) “Hekimlerin Reçeteleme Kararında İlaç Mümessillerinin Rolü: Pilot Çalışma “ Uluslararası Sosyal Araştırmalar Dergisi, Cilt: 10, Sayı: 54, s. 899-905.Tübitak, (2003) “Vizyon 2023 Teknoloji Öngörüsü Projesi: Sağlık Ve İlaç Paneli Ön Rapor”, Ankara.Wang, Y., Adelman, R. A. (2009) “A Study of Interactions Between Pharmaceutical Representatives And Ophthalmology Trainees” American Journal Of Ophthamology, Vol. 148, No. 4, pp. 619-622.Workneh, B. D., Gebrehiwot, M. G., Bayo, T. A., Gidey, M. T., Belay, Y. B., Tesfaye, D. M., Kassa, T. T. (2016) “Influence of Medical Representatives On Prescribing Practices in Mekelle, Northern Ethiopia” Plos One, Vol. 11, No. 6, pp. 1-11.